AOA
AOA Dx is a biotechnology company with a team of entrepreneurs that brings innovative, impactful, and cost-effective medical technologies from research and development into the hands of providers and patients. The company is driven by a mission to bring to market the first accurate early-stage non-invasive ovarian cancer diagnostic test that will improve clinical practice and help reduce patient mortality.
AOA
Industry:
Biotechnology Health Care Health Diagnostics
Founded:
2020-01-01
Address:
Boulder, Colorado, United States
Country:
United States
Website Url:
http://www.aoadx.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
24.5 M USD
Technology used in webpage:
Euro U.S. Server Location EmbedSocial
Similar Organizations
Century Therapeutics
Century Therapeutics is a developer of allogeneic living drugs created to offer treatment for cancer.
Cognito Therapeutics
Cognito Therapeutics is a focused on discovering and developing new Alzheimer's treatments and preventive therapies.
Group K Diagnostics
We put patient health 1st by revolutionizing rapid blood testing with a hand-held chemistry and ID analyzer for everyone, all in one.
Instadiagnostics
Instadiagnostics Inc., is developing a rapid, quantitative, point-of-care (POC) diagnostic platform.
Mirvie
Mirvie is a biotech company that creates precise, actionable, and non-invasive tests for maternal-fetal health.
NanoCellect Biomedical
NanoCellect Biomedical is a biotech company developing and commercializing cell analysis and sorting.
Pleno
Pleno is a biotechnology company that aims speeding up disease diagnosis and treatment.
Prolocor
Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases.
Current Employees Featured
Founder
Investors List
Gore Range Capital
Gore Range Capital investment in Series A - AOA
LabCorp Venture Fund
LabCorp Venture Fund investment in Series A - AOA
Good Growth Capital
Good Growth Capital investment in Series A - AOA
Astia
Astia investment in Series A - AOA
The Helm
The Helm investment in Series A - AOA
RH Capital
RH Capital investment in Series A - AOA
LongeVC
LongeVC investment in Series A - AOA
VU Venture Partners
VU Venture Partners investment in Series A - AOA
Cancer Fund
Cancer Fund investment in Series A - AOA
Adaptive Capital Partners
Adaptive Capital Partners investment in Series A - AOA
Official Site Inspections
http://www.aoadx.com Semrush global rank: 7.89 M Semrush visits lastest month: 673
- Host name: 151.101.130.159
- IP address: 151.101.130.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "AOA"
About Us – AOA DX
[email protected]. [email protected]. 6860 Broadway, Denver CO 80221. Follow. Instagram Linkedin Twitter. Website by Sungraphic ...See details»
AOA - Crunchbase Company Profile & Funding
Contact Email [email protected] AOA Dx is a biotechnology company with a team of entrepreneurs that brings innovative, impactful, and cost-effective medical technologies from research and development into the hands of providers and …See details»
Our Team – AOA DX
Anna is an innovator and a dynamic business leader with a passion for advancing healthcare through world-class diagnostics. As the Chief Reglatory Officer of AOA, she is pioneering the development of the groundbreaking GlycoLocate …See details»
AOA Dx Company Profile 2024: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for AOA Dx. Use the PitchBook Platform to explore the full profile.See details»
AOA Dx - LinkedIn
AOA Dx | 6,664 followers on LinkedIn. Revolutionizing early diagnosis of Ovarian Cancer | AOA Dx is developing the next frontier in early-stage cancer detection for women through its …See details»
AOA Dx: Blood Test for Early Detection of Ovarian …
Dec 8, 2022 Blood Test for Early Detection of Ovarian Cancer . Founded in 2020 by Alex Fisher, Anna Jeter, and Oriana Papin-Zoghbi, AOA Dx has 25 employees based in Denver, CO, USA.See details»
AOA Dx Company Profile - Office Locations, Competitors, Revenue …
AOA Dx has 5 employees at their 1 location and $7 m in total funding,. See insights on AOA Dx including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
AOA Dx Company Profile: , Investments, Contact Information, …
AOA Dx is developing the next frontier in early-stage cancer detection through its pioneering work in glycolipids and proprietary biomarker technology. Our revolutionary tumor marker …See details»
AOA Dx Inc | F6S
Aoadx.com. About AOA Dx Inc. AOA seeks to revolutionize early-stage diagnosis of ovarian cancer by developing a non-invasive ovarian cancer diagnostic liquid biopsy test that will …See details»
AOA Company Profile | Management and Employees List - Datanyze
Www.aoadx.com . AOA Profile and History. AOA's mission is to bring to market the first accurate early stage non-invasive ovarian cancer diagnostic test that will improve clinical practice, help …See details»
AOA Inc - VentureRadar
"AOA Dx is revolutionizing early cancer detection with a groundbreaking platform focused on women's health. Utilizing GlycoLocate™, an AI-enabled technology, and AKRIVIS GD™, a novel blood test, AOA Dx harnesses the power of tumor marker gangliosides to detect early-stage ovarian cancer.See details»
Team - AOA DX
At AOA Dx, she uses her technical expertise to support scientists across the organization in our mission to Transform Women’s Health. Megan earned her Masters in Comparative and …See details»
Meet Alex Fisher, Co-Founder of AOA Dx — OXONIAN VENTURES
Dec 8, 2023 Each year 8.5 million women are tested for suspected ovarian cancer in North America and Europe alone, representing a $6B market opportunity. Early diagnosis can save …See details»
AOA Dx - Work in biotech
AOA Dx focuses on early cancer detection. Their unique GlycoLocate platform uses AI to detect gangliosides that may be used as tumor biomarkers to enable earlier detection and effective …See details»
Member Company Spotlight: AOA Dx is Aiming to Detect Ovarian …
Apr 20, 2022 AOA Dx Inc has partnered with a leading researcher at McGill University to develop the first early stage ovarian cancer liquid biopsy diagnostic test. The co-founders have …See details»
AOA Dx - Products, Competitors, Financials, Employees, …
About the National Foundation for Cancer Research The National Foundation for Cancer Research (NFCR) is a 501(c)(3) nonprofit organization co-founded in 1973 by Nobel Laureate Dr. Albert Szent-Györgyi and Attorney/Business Entrepreneur Franklin Salisbury, Sr. NFCR provides scientists in the lab with the critical seed funding they need to make game-changing …See details»
AOA - Overview, News & Similar companies | ZoomInfo.com
Oct 12, 2023 www.aoadx.com. Revenue <$5 Million. Industry Test & Measurement Equipment Manufacturing . Recent News & Media. AOA Dx Raises $17M in Funding. Oct 12, 2023. …See details»
AOA Dx secures $17 Million to revolutionize the diagnosis of …
Oct 12, 2023 New York, NY: AOA Dx, a startup biotech company developing the first early detection test for ovarian cancer, is announcing an oversubscribed $17 million round led by …See details»
AOA Dx Closes $7 million Funding Round to Bring the First …
AOA Dx Inc, a female led company, is committed to bringing the first accurate early stage liquid biopsy ovarian cancer diagnostic test to market that will improve clinical practice, help reduce …See details»